JeffreyBTraversMD
Dermatology • Dayton, OHProfessor, Dermatology, Indiana University School of Medicine
Dr. Travers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
725 Colonel Glenn Hwy
Dayton, OH 45435Phone+1 937-245-7200Fax+1 937-245-7922
Education & Training
University of ColoradoResidency, Dermatology, 1992 - 1995
OhioHealth/Riverside Methodist HospitalInternship, Transitional Year, 1991 - 1992
Ohio State University College of MedicineClass of 1991
Certifications & Licensure
OH State Medical License 2014 - 2025
IN State Medical License 1995 - 2015
CO State Medical License 1993 - 1995
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2007
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis Start of enrollment: 2017 Mar 28
- Photodynamic Therapy-Induced Immune Modulation: Part III Start of enrollment: 2019 Apr 01
- Gene Expression Changes In Young and Geriatric Skin Start of enrollment: 2019 Sep 06
- Join now to see all
Publications & Presentations
PubMed
- Mechanistic Insights and Pharmacological Approaches for Nitrogen and Sulfur Mustards and Their Implications as Therapeutic Agents.Madison Owens, Anita Thyagarajan, Jeffrey B Travers, Ravi P Sahu
Journal of Applied Toxicology. 2025-03-04 - Relevance of the Platelet-activating factor system in chemical warfare agents-induced effects.Anita Thyagarajan, Jeffrey B Travers, Ravi P Sahu
Free Radical Biology & Medicine. 2025-02-16 - 1 citationsA review of biosimilars in psoriasis: impacts on efficacy, safety, access, and a first-hand look at biosimilar cost savings within the department of veterans affairs.Rebecca Reese, Shiva Ram Nanavath, Jennifer Martin, Jeffrey B Travers, Craig A Rohan
The Journal of Dermatological Treatment. 2024-12-01
Journal Articles
- Early Assessment of Burn Severity in Human Tissue Ex Vivo with Multi-Wavelength Spatial Frequency Domain ImagingRichard Simman, Nathan M Weir, Smita Krishnamurthy, Jeffrey B Travers, Michael Kent, ScienceDirect
Press Mentions
Laser Treatment for Non-Melanoma Skin CancerSeptember 6th, 2024- Laser Treatment of Nonmelanoma Skin Cancer Gaining GroundAugust 21st, 2024
- Trial Yields Evidence That Laser Resurfacing May Prevent NMSC in Aged SkinJune 11th, 2021
- Join now to see all
Grant Support
- Oxidized Lipids and UV ImmunosuppressionDAYTON VA MEDICAL CENTER2010–2028
- Wounding Therapy and PhotocarcinogenesisWRIGHT STATE UNIVERSITY2014–2027
- Oxidized lipids and microvesicle particles as effectors for chemical threats to skinWRIGHT STATE UNIVERSITY2023–2026
- UVB radiation-generated microvesicle particles as effectors for photosensitivityWRIGHT STATE UNIVERSITY2021–2026
- UVB radiation-generated microvesicle particles as effectors for photosensitivityWRIGHT STATE UNIVERSITY2021–2026
- Platelet Activating Factor And Epidermal CytotoxicityNational Heart, Lung, And Blood Institute1999–2012
- Bacterial Products As Potentiaters Of Atopic Dermatitis (AD)National Institute Of Allergy And Infectious Diseases2007–2010
- Platelet Activating Factor And Epidermic CytotoxicityNational Heart, Lung, And Blood Institute2003–2007
- Bacterial Products As Potentiaters Of ADNational Institute Of Allergy And Infectious Diseases2006
- Platelet Activating Factor In Keratinocyte FunctionNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1997–2001
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
